Cordia Bancorp Inc. Reports Fourth Quarter Results
Mar 03, 2016 21:05 pm UTC| Business
MIDLOTHIAN, Va., March 03, 2016 -- Cordia Bancorp Inc. (“Cordia”) (NASDAQ:BVA), parent company of Bank of Virginia, reported a net loss of $127,000 or $(0.02) per share for the fourth quarter of 2015, compared to net...
Mar 03, 2016 21:05 pm UTC| Business
TUSTIN, Calif., March 03, 2016 -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the body's immune system to fight cancer, today...
Inventure Foods Reports Fourth Quarter and Fiscal 2015 Financial Results
Mar 03, 2016 21:05 pm UTC| Business
PHOENIX, March 03, 2016 -- Inventure Foods, Inc. (NASDAQ:SNAK) (“Inventure Foods” or the “Company”), a leading specialty food marketer and manufacturer, today reported financial results for the fourth quarter and fiscal...
Wingstop Inc. Reports Fiscal Fourth Quarter and Fiscal Year 2015 Financial Results
Mar 03, 2016 21:05 pm UTC| Business
DALLAS, March 03, 2016 -- Wingstop Inc. (NASDAQ:WING) today announced fiscal fourth quarter and fiscal year 2015 financial results for the period ended December26, 2015 and annual guidance for fiscal year 2016. ...
Mar 03, 2016 21:05 pm UTC| Business
Southfield, Michigan , March 03, 2016 -- Credit Acceptance has been named, for a third year in a row, as one of the 2016 Fortune 100 Best Companies to Work For. The list recognizes companies that have exceptional...
Diversicare Announces 2015 Fourth Quarter Results
Mar 03, 2016 21:05 pm UTC| Business
BRENTWOOD, Tenn., March 03, 2016 -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR), a premier provider of long-term care services, today announced its results for the fourth quarter ended December31, 2015. The...
Atara Bio Announces Fourth Quarter and Full Year 2015 Financial Results and Recent Highlights
Mar 03, 2016 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 03, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases...